Trial Profile

A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 09 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Squaric acid dibutylester (Primary)
Indications Herpes labialis
Focus Adverse reactions
Sponsors Squarex

Most Recent Events

19 May 2021 Status changed from suspended to discontinued.
01 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Oct 2018.
01 Aug 2018 Status changed from recruiting to suspended.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com